至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Rapid generation of neutralizing antibody responses in COVID-19 patients

Journal Pre-proof. 2020-05; 
Mehul S. Suthar, Matthew G. Zimmerman, Robert C. Kauffman, Grace Mantus, Susanne L. Linderman, William H. Hudson, Abigail Vanderheiden, Lindsay Nyhoff, Carl W. Davis, Seyi Adekunle, Maurizio Affer, Melanie Sherman, Stacian Reynolds, Hans P. Verkerke, David N. Alter, Jeannette Guarner, Janetta Bryksin, Michael Horwath, Connie M. Arthur, Natia Saakadze, Geoffrey Hughes Smith, Srilatha Edupuganti, Erin M. Scherer, Kieffer Hellmeister, Andrew Cheng, Juliet A. Morales, Andrew S. Neish, Sean R. Stowell, Filipp Frank, Eric Ortlund, Evan Anderson, Vineet D. Menachery, Nadine Rouphael, Aneesh Mehta, David S. Stephens, Rafi Ahmed, John D. Roback, Jens Wrammer
Products/Services Used Details Operation
Codon Optimization The receptor-binding domain consisting of amino acids 319 (arginine) to 541 (phenylalanine) of the SARS-Cov-2 S gene was amplified by PCR using a mammalian codon-optimized sequence as the DNA template (Genscript MC_0101081). Get A Quote

摘要

关键词